Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-03 Sale |
2024-04-05 4:55 pm |
Kinnate Biopharma Inc. | KNTE | Farzan Nima CHIEF EXECUTIVE OFFICER |
2,186 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-30 Option Award |
2024-06-03 4:15 pm |
N/A 2034-05-29 |
Keros Therapeutics Inc. | KROS | Farzan Nima Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:38 pm |
N/A 2033-06-05 |
Keros Therapeutics Inc. | KROS | Farzan Nima Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-02-10 Option Award(A) |
2023-02-15 11:01 am |
N/A 2033-02-10 |
Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer |
750,000 | $0 | 750,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 5:00 pm |
N/A 2033-02-10 |
Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer |
750,000 | $0 | 215,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:24 pm |
N/A 2032-05-31 |
Keros Therapeutics Inc. | KROS | Farzan Nima Director |
8,293 | $0 | 8,293 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:00 pm |
N/A 2032-02-11 |
Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:29 pm |
N/A 2031-05-31 |
Keros Therapeutics Inc. | KROS | Farzan Nima Director |
8,293 | $0 | 8,293 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-16 5:54 pm |
N/A 2031-02-12 |
Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer |
275,000 | $0 | 275,000 (Direct) |
View |
Ownership |
2020-12-02 9:14 pm |
2020-03-23 2030-03-23 |
Kinnate Biopharma Inc. | KNTE | Farzan Nima President and CEO |
0 | $0 | 1,719,055 (Direct) |
View |
| 2020-05-29 Option Award |
2020-05-29 5:19 pm |
N/A 2030-05-29 |
Keros Therapeutics Inc. | KROS | Farzan Nima Director |
8,500 | $0 | 8,500 (Direct) |
View |